Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Medical Device
Magloy Tech runs a Medical Device operation from Singapore. The record marks it privately held. It holds one address on record, all in Singapore. The record counts 5 people. One Singapore registration (UEN) is a confirmed match. The latest round on record is Seed at US$517.2K. The record links two similar brands, most of them in Medical Equipment Manufacturing.
UEN202003387Z
| MAGLOY TECH PTE. LTD. | UEN 202003387Z |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Magloy Tech is pioneering the future of medical implants with its innovative bioresorbable magnesium technology. As a forward-thinking spin-off from Singapore, we're dedicated to revolutionizing orthopedic and trauma surgery with solutions that prioritize sustainability and patient welfare. Our mission is to enhance patient recovery and eliminate the necessity for secondary surgeries.
Our flagship product, ResoMag®, epitomizes our commitment to innovation. This advanced bioresorbable magnesium technology offers unparalleled mechanical stability and controlled degradation thereby fostering efficient bone healing. Designed to naturally dissolve, our implants, including state-of-the-art cranial plating systems and compression screws, leave healthy bone tissue, significantly lowering the risks associated with traditional implants.
Magloy Tech champions collaboration and excellence. We work alongside leading biomedical implant makers to diversify our portfolio, encompassing orthopedic, neurosurgery, and maxillofacial applications. Our team, a blend of materials scientists and clinical physicians, integrates cutting-edge magnesium alloy research with medical insights, creating solutions that resonate with both patient and surgeon needs.
We aim to redefine medical care, striving for a future where surgeries are less intrusive, recovery is quicker, and patient comfort is paramount. By obviating the need for implant removal surgeries, we're not just advancing medical technology; we're improving life outcomes.
Magloy Tech invites collaboration from partners, investors, and healthcare professionals. Together, we can set new healthcare standards, ensuring our advancements in medical implant technology lead to a healthier tomorrow.
Join us in this transformative journey, shaping a future where medical interventions are more effective, less invasive, and universally beneficial.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2020 to 2026 |
| Seed · 13 Jan 2020 | US$ 517.2K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. MAGLOY TECH PTE. LTD. (UEN 202003387Z), high confidence.
The record holds 5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Singapore only. Primary: 3 Research Link, GRIP HQ, #01-02, Innovation 4.0, Singapore 117602.
One round. Latest 13 January 2020: Seed, US$517,200.
16 profiles list Magloy Tech as a peer — 94th percentile in Medical Device. It lists ten peers of its own. Osteopore (OSX.AX) and UroMedTech Pte Ltd list it back.